The procedures were performed in Italy and Sweden. The system was designed for less wear than a metal resurfacing implant. It is intended for use in patients who have glenohumeral joint disease due to non-inflammatory, inflammatory and post-traumatic arthritis.
More Articles on Orthopedic Devices:
15 of the Most Profitable Orthopedic & Spine Device Companies in 2011
U.S. Orthopedic & Spine Bracing Market to Reach $2B in 2012
Generic Orthopedic Implant Company Signs Agreement With Premier
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
